ES2062754T3 - Eliminacion de linfocitos activados. - Google Patents

Eliminacion de linfocitos activados.

Info

Publication number
ES2062754T3
ES2062754T3 ES91900757T ES91900757T ES2062754T3 ES 2062754 T3 ES2062754 T3 ES 2062754T3 ES 91900757 T ES91900757 T ES 91900757T ES 91900757 T ES91900757 T ES 91900757T ES 2062754 T3 ES2062754 T3 ES 2062754T3
Authority
ES
Spain
Prior art keywords
elimination
activated lymphocytes
lymphocytes
activated
mitogenos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91900757T
Other languages
English (en)
Inventor
Eberhard Wecker
Anneliese Schimpl
Rabbe Nordstrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedMark Pharma GmbH
Original Assignee
MedMark Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedMark Pharma GmbH filed Critical MedMark Pharma GmbH
Application granted granted Critical
Publication of ES2062754T3 publication Critical patent/ES2062754T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

ELIMINACION DE LINFOCITOS ACTIVADOS. LA 2 IGENOS O MITOGENOS EN MAMIFEROS.
ES91900757T 1989-12-12 1990-12-11 Eliminacion de linfocitos activados. Expired - Lifetime ES2062754T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3941009A DE3941009A1 (de) 1989-12-12 1989-12-12 Eliminierung von aktivierten lymphozyten

Publications (1)

Publication Number Publication Date
ES2062754T3 true ES2062754T3 (es) 1994-12-16

Family

ID=6395316

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91900757T Expired - Lifetime ES2062754T3 (es) 1989-12-12 1990-12-11 Eliminacion de linfocitos activados.

Country Status (13)

Country Link
EP (1) EP0505414B1 (es)
JP (1) JPH05504132A (es)
AT (1) ATE102038T1 (es)
AU (1) AU638086B2 (es)
CA (1) CA2071520C (es)
DE (2) DE3941009A1 (es)
DK (1) DK0505414T3 (es)
ES (1) ES2062754T3 (es)
FI (1) FI922710A0 (es)
HU (1) HU217586B (es)
NO (1) NO922304D0 (es)
RU (1) RU2100025C1 (es)
WO (1) WO1991008746A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5517234A (en) * 1993-10-26 1996-05-14 Gerber Systems Corporation Automatic optical inspection system having a weighted transition database
DE19822509A1 (de) * 1998-05-19 1999-11-25 Medmark Pharma Gmbh Edelfosin zur Behandlung von Hirntumoren
DE19829448A1 (de) * 1998-07-01 2000-10-12 Medmark Pharma Gmbh 1-Octadecyl-2-methyl-sn-glycero-3-phosphocholin (ET180CH3) zur Behandlung von humanen Mammakarzinomen
JP2009520730A (ja) 2005-12-23 2009-05-28 ヤド・テヒノロギース・ゲーエムベーハー アレルギー性疾患を治療および予防するための手段および方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen

Also Published As

Publication number Publication date
RU2100025C1 (ru) 1997-12-27
EP0505414A1 (de) 1992-09-30
HU9201976D0 (en) 1992-09-28
DK0505414T3 (da) 1994-05-09
HU217586B (hu) 2000-02-28
CA2071520C (en) 2002-10-01
EP0505414B1 (de) 1994-03-02
FI922710A7 (fi) 1992-06-11
AU6954391A (en) 1991-07-18
HUT60927A (en) 1992-11-30
DE3941009A1 (de) 1991-06-13
NO922304L (no) 1992-06-11
ATE102038T1 (de) 1994-03-15
WO1991008746A1 (de) 1991-06-27
DE59004836D1 (de) 1994-04-07
JPH05504132A (ja) 1993-07-01
CA2071520A1 (en) 1991-06-13
NO922304D0 (no) 1992-06-11
FI922710A0 (fi) 1992-06-11
AU638086B2 (en) 1993-06-17

Similar Documents

Publication Publication Date Title
MA22573A1 (fr) Mutants de substilisine .
DE68914929D1 (de) Emulgierte Zusammensetzung.
BR8903526A (pt) Composicao de lubrificantes e aplicacao
DE3853340D1 (de) Dien-Blockpolymer und Polymerzusammensetzung.
DE68918585D1 (de) Linearlager.
DE58904438D1 (de) Schmierstoffzusammensetzung.
DK625289A (da) Bicyclo(3.3.1)nonan-derivater
DE68913050D1 (de) Antithrombotische zusammensetzung.
FI890611L (fi) 3'-deamino-4'-deoxi-4'-amino -antracykliner.
BR8900918A (pt) Disposicao de mancal
DE69028776D1 (de) Schmiermittelzusammensetzung
BR8900293A (pt) Composicao de polimero de poliecetona
FR2659658B1 (fr) Silice traitee par un organosilicone et composition la contenant.
ATA40789A (de) Gleitlager
FI910504A7 (fi) Voiteluainekoostumus
AR244320A1 (es) Composicion lubricante
BR8902730A (pt) Composicao de polimero
FI900149L (fi) Foerfarande foer selektiv flotation av fosformineraler.
ES2062754T3 (es) Eliminacion de linfocitos activados.
PT91966A (pt) Mesa de entrada dupla
ES2023098A4 (es) Objetivo de artilleria aerea.
IT9022047A0 (it) 13-desosso-4'-desossi-4'-iodoantracicline
KR880001256U (ko) 키타의 전음 장치
FR2650950B1 (fr) Capillo 47
JO1565B1 (en) Mathematical mind game

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 505414

Country of ref document: ES